Form 4: IGM Biosciences Officer Sells Shares to Cover Tax Obligations

Steven Weber, Principal Accounting Officer of IGM Biosciences, sold 495 shares of common stock on June 14, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On June 14, 2024, Steven Weber, the Principal Accounting Officer of IGM Biosciences, sold 495 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $7.5753, with individual trades ranging from $7.26 to $7.94.
• Following the transaction, Weber directly owns 26,012 shares of IGM Biosciences common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't indicate any significant positive or negative outlook for the company.

Industry Context

Form 4 filings are a routine part of insider trading activity and are required by the SEC to ensure transparency in the market. This sale appears to be related to tax obligations, which is a common reason for such transactions.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates